Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women
NCT00651846Phase 4Completed
- Sponsor
- Bayer
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of drospirenone in contraception (2 arms), sponsored by Bayer. Primary endpoints: Factor VIII activity, Fibrinogen and 3 more. Started Jun 2003; status: completed.
02
Drugs
drospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00651846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00651846.